Related Experiment Video
Updated: Jan 13, 2026

07:12
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Published on: August 2, 2021
4.1K
Enhancing effect of cognitive control training on rTMS treatment in depression: A study protocol for a multicenter
Iris Dalhuisen1, Marloes Wurkum1, Chris Bervoets2
1Department of Psychiatry, Radboud University Medical Center, Nijmegen, the Netherlands; Donders Institute for Brain Cognition and Behavior, Centre for Medical Neuroscience, Nijmegen, the Netherlands.
Contemporary Clinical Trials
|January 6, 2026
Summary
This study tests if adding cognitive control training (CCT) to repetitive transcranial magnetic stimulation (rTMS) improves depression treatment. The goal is to find a more effective and cost-efficient therapy for major depressive disorder (MDD).
Area of Science:
- Neuroscience
- Clinical Psychology
- Psychiatry
Background:
- Repetitive transcranial magnetic stimulation (rTMS) is effective for major depressive disorder (MDD), but patient response varies.
- Adjunctive therapies like psychotherapy are explored to enhance rTMS efficacy.
- Cognitive control training (CCT) targets similar neural circuits as rTMS and shows antidepressant potential.
Purpose of the Study:
- To investigate if rTMS augmented with CCT is more (cost-)effective than rTMS alone in reducing depressive symptoms.
- To assess the synergistic effects of combining rTMS with CCT.
- To explore a pragmatic, time-efficient, and potentially cost-effective solution for improving rTMS therapeutic response.
Main Methods:
- An international multicenter clinical trial randomizing 132 adult patients with depression.
- Treatment groups: rTMS augmented with CCT versus rTMS with a placebo task.
- Primary outcome: change in depressive severity (HDRS-17) after 8 weeks; secondary outcomes include economic evaluation and response/remission rates.
Main Results:
- The study is currently ongoing, and results are pending.
- The primary outcome measure is the change in the Hamilton Depression Rating Scale (HDRS-17) after an 8-week treatment period.
- Secondary outcome measures include response and remission rates, as well as an economic evaluation.
Conclusions:
- This trial aims to enhance the (cost-)effectiveness of rTMS for depression by combining it with CCT.
- Findings may inform the development of more personalized and cost-effective depression interventions.
- The study seeks to optimize treatment strategies for patients with major depressive disorder.

